Disruption of TOP2 function leads to cell death, and several anticancer agents, such as etoposide and the anthracyclines like doxorubicin, target TOP2 in order to kill cancer cells (Deweese and Osheroff 2009). The gene discussed is TOP2A; the disease is cancer.